MCQ Chem
MCQ Chem
PHYSICOCHEMICAL
CHARACTERIZATION OF
NEW DRUG MOLECULES
05/12/2015 NGSMIPS 2
PREFORMULATION
It is defined as the phase of research and development in
which preformulation studies characterize physical and
chemical properties of a drug molecule in order to
develop safe, effective and stable dosage form.
05/12/2015 NGSMIPS 3
OBJECTIVES
To establish the physico-chemical parameters of a new drug entity
05/12/2015 NGSMIPS 4
Major Area of Preformulation
Research
➢ ORGANOLEPTIC CHARACTERS
➢ BULK CHARACTERS
❑ Crystallinty and polymorphism
❑ Hygroscopicity
❑ Fine particle characterization
❑ Powder flow properties
➢ SOLUBILITYANALYSIS
❑ ionization constant-PKa
❑ pH solubility profile
❑ Common ion effect-Ksp
❑ Thermal effects
05/12/2015 NGSMIPS 5
❑ Solubilization
❑ Partition co-efficient
❑ Dissolution
➢ STABILITYANALYSIS
❑ Stability in toxicology formulations
❑ Solution stability
❑ pH rate profile
❑ Solid state stability
❑ Bulk stability
❑ Compatibility
05/12/2015 NGSMIPS 6
ORGANOLEPTIC CHARACTERS
❖ Colour,odour, taste of the new drug must be
recorded
COLOUR ODOUR TASTE
❑ Off-white ❑ pungent ❑ Acidic
05/12/2015 NGSMIPS 7
BULK CHARACTERIZATION
Crystallinity
Crystal habit & internal structure of drug can affect bulk &
physicochemical property of molecule.
05/12/2015 NGSMIPS 8
Different shapes of crystals
05/12/2015 NGSMIPS 9
Different shapes of crystals
Depending on internal structure compounds is classified as
1. Crystalline
2. Amorphous
Crystalline compounds are characterized by repetitious spacing of
constituent atom or molecule in three dimensional array.
In amorphous form atom or molecule are randomly placed.
Solubility & dissolution rate are greater for amorphous form than
crystalline, as amorphous form has higher thermodynamic energy.
05/12/2015 NGSMIPS 10
Polymorphism
It is the ability of the compound to crystallize as more than one
distinct crystalline species with different internal lattice.
05/12/2015 NGSMIPS 11
Polymorphism
Polymorphs differ from each other with respect to their physical
property such as
• Solubility
• Melting point
• Density
• Hardness
• Compression characteristic
Eg. 1)Chloromphenicol exist in A,B & C forms, of these B form is
05/12/2015 NGSMIPS 12
ANALYTICAL METHODS FOR THE
CHARACTERIZATION OF SOLID FORMS
Microscopy
Hot stage microscopy
Thermal analysis
X-ray diffraction
Infrared (IR) spectroscopy
Proton magnetic resonance (PMR)
Nuclear magnetic resonance (NMR)
Scanning electron microscopy (SEM)
05/12/2015 NGSMIPS 13
Microscopy
Material with more than one refractive index are anisotropic & appear
bright with brilliant colors against black polarized background.
Isotropic material have single refractive index and this substance do not
transmit light with crossed polarizing filter and appears black.
Advantage :
By this method, we can study crystal morphology & difference between
polymorphic form.
Disadvantage :
This require a well trained optical crystallographer, as there are many
possible crystal habit & their appearance at different orientation.
05/12/2015 NGSMIPS 14
Hot stage microscopy
The polarizing microscope fitted with hot stage is useful for
investigating polymorphism, melting point & transition temp.
Disadvantage :
In this technique, the molecules can degrade during the melting
process.
05/12/2015 NGSMIPS 15
Thermal analysis
Differential scanning calorimetry (DSC) & Differential thermal analysis
are (DTA) are particularly useful in the investigation of polymorphism.
05/12/2015 NGSMIPS 16
X-ray diffraction
Working :
When beam of nonhomogenous X-ray is allow to pass through the
crystal, X-ray beam is diffracted & it is recorded by means of
photographic plate.
05/12/2015 NGSMIPS 17
Random orientation of crystal lattice in the powder causes the
X-ray to scatter in a reproducible pattern of peak intensities.
05/12/2015 NGSMIPS 18
HYGROSCOPICITY
Many drug substances, particularly water –soluble salt forms, have a
tendency to adsorb atmospheric moisture.
Adsorption and moisture content depend upon the atmospheric
humidity, temperature, surface area, exposure and the mechanism of
moisture uptake.
05/12/2015 NGSMIPS 19
Hygroscopicity is tested by:
Samples are exposed to the moisture
✓ Gas chromatography
05/12/2015 NGSMIPS 20
PARTICLE SIZE
Particle size is characterized using these terms :
Very coarse, Coarse, Moderately coarse, Fine ,Very
fine .
Particle size can influence variety of important factors :
- Dissolution rate
- Suspendability
- Uniform distribution
- Penetrability
- Lack of grittiness
05/12/2015 NGSMIPS 21
Methods to Determine Particle Size
Sieving (5µ-150µ)
Microscopy(0.2µ-100µ)
Sedimentation rate method(1µ-200µ)
Light energy diffraction(0.5µ-500µ)
Laser holography(1.4µ-100µ)
05/12/2015 NGSMIPS 22
POWDER FLOW PROPERTIES
➢ Powder flow properties can be affected by change in
particle size, shape & density.
05/12/2015 NGSMIPS 24
Methods to determine angle of
repose
➢ Static angle of
repose
Fixed-funnel
method
Fixed-cone method
➢ Kinetic or dynamic
method
Rotating cylinder
method
Tilting box method
05/12/2015 NGSMIPS 25
Determination of Powder Flow Properties
05/12/2015 NGSMIPS 26
Determination of Powder Flow Properties
12-16 Good
23-35 Poor
33-38 Very Poor
>40 Extremely Poor
05/12/2015 NGSMIPS 27
SOLUBILITY STUDIES
1. Solution phase equilibrium with solid phase at a stated temperature and
pressure .
2. Determines amount of drug dissolved , amount of drug available for
absorption.
3. Solubility reduction is carried out in certain conditions:
❖ Enhancement of chemical stability.
❖ taste masking products.
❖ Production of sustained release products.
Descriptive term Parts of solvent required for 1 part of
❖ Table: Solubility based classificati onsolute
of drug
Very soluble Less than 1
Freely soluble From 1 to 10
Soluble From 10 to 30
Sparingly soluble From 30 to 100
Slightly soluble From 100 to 1000
Very slightly soluble From 1000 to 10,000
Practically insoluble 10,000 and over
05/12/2015 NGSMIPS 28
The equilibrium solubility is based on the phase-solubility technique
proposed by Higuchi-Connors .
Method
Drug dispersed in solvent in a closed container
05/12/2015 NGSMIPS 29
pKa determination
pKa is the dissociation constant of a drug
The un-ionized drug is lipid soluble thus permeates through lipid
membrane.
The ionized substance is lipid insoluble therefore permeation is slow
Degree of ionization depends on pH
Henderson-Hasselbalch equation
For basic compounds: [ionized]
pH = pKa +
[un − ionized]
[un − ionized]
For acidic compounds: pH = pKa +
[ionized]
( pH − pKa )
%ionized = 10
( pH − pKa )
1 +10
Determined by uv spectroscopy, potentiometric titration, titrimetric
method
05/12/2015 NGSMIPS 30
SOLUBILIZATION
05/12/2015 NGSMIPS 31
➢It is the process by which apparent solubility of an otherwise
sparingly soluble substance is increased by the presence of surfactant
micelles .
❑ MICELLES: -
05/12/2015 NGSMIPS 32
➢ When surfactants are added to the liquid at low concentration they
tend to orient at the air-liquid interface .
05/12/2015 NGSMIPS 33
General Method of Increasing
the Solubility
➢ Addition of co-solvent
➢ pH change method
➢ Reduction of particle size
➢ Temperature change method
➢ Hydotrophy
➢ Addition of Surfactant
➢ Dielectrical Constant
➢ Complexation
05/12/2015 NGSMIPS 34
Partition Coefficient
A measurement of drug lipophilicity i,e the ability to cross the cell
membrane p = c o rg a n ic
o/a
c a q ue o u s
Distribution coefficient
( pH − pKa)
log10D = log 10P − log 10 (1 +10 )
For acids:
pKa − pH
log D = log P − log (1 + 1 0 )
For bases : 10 10 10
05/12/2015 NGSMIPS 35
SHAKE FLASK METHOD
05/12/2015 NGSMIPS 36
DISSOLUTION
Rate Rate
constant of constant of
dissolution absorption
K d K a
Solid drug in Drug in solution Drug systemic
the G.I Fluid in the G.I fluid circulation
05/12/2015 NGSMIPS 37
Constant surface area is obtained by compressing powder into a disc of
known area with a die and punch apparatus.
05/12/2015 NGSMIPS 38
STABILITY ANALYSIS
1. Solution stability
2. Solid state stability
SOLUTION STABILITY
▪ The decomposition of drug occurs through hydrolysis, oxidation,
photolysis.
➢ Hydrolysis (anaesthetics, vitamins etc )
a) Ester hydrolysis
R’-COOR + H+ + OH- RCOOH + ROH
ester acid alcohol
b) Amide hydrolysis
RCONHR’ + H+ + OH- RCOOH + H2N-R’
amide acid amine
05/12/2015 NGSMIPS 39
➢ Oxidation
used to evaluate the stability of pharmaceutical preparations
Autoxidation
Materials + molecular oxygen
homolytic fission
05/12/2015 NGSMIPS 40
➢ Photolysis
pharmaceutical compounds
exposure to uv light
SOLID-STATE STABILITY
Vials exposed to oxygen and nitrogen to study the surface oxidation and
chemical stability , polymorphic changes and discolouration.
k H
= [gpl].k 0
gpl= concentration of water in atmosphere in units of grams of water per liter
of dry air .
05/12/2015 NGSMIPS 43
Drug- excipient compatibility
➢ An decrease in potency
05/12/2015 NGSMIPS 44
METHOD
Drug + Excipients
(1:1)
05/12/2015 NGSMIPS 45
05/12/2015 NGSMIPS 46
CONCLUSION
Preformulation studies on a new drug molecule provide
useful information for subsequent formulation of a
physicochemically stable and biopharmaceutically
suitable dosage form.
05/12/2015 NGSMIPS 47
REFERENCE
Leon Lachman, Liberman. The theory and practice of
Industrial pharmacy, Edn 4. CBS publishing house, New
Delhi.2013 p:217-307.
Banker GS, Rhodes CT. Modern pharmaceutics, Edn 4.
Marcel Dekker, New York. 2002 p:167-184.
Loyd V. Allen, Nicholas G.popovich, Howard C. Ansel.
Ansel’s pharmaceutical Dosage forms & Drug delivery
systems, Edn 8. B.I.Publication pvt. Ltd, p:187-193,42
& 43,126-133.
Brahmankar D.M, Jaiswal BS. Biopharmaceutics
and pharmacokinetics a Treatise, Edn 2. Vallabh
Prakashan, Nagpur. 2009; p: 37-45.
05/12/2015 NGSMIPS 48
05/12/2015 NGSMIPS 49